| (a) |
Hansen, C. et al.
(1999) Increased sulfation of orbital glycosaminoglycans in
Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 84,
1409-1413. |
| (b) |
Bahn, R.S. and
Heufelder, A.E. (1993) Pathogenesis of Graves' ophthalmopathy.
N. Engl. J. Med. 329, 1468-1475. |
| (c) |
Grubeck-Loebenstein,
B. et al. (1994) Retrobulbar T cells from patients with
Graves' ophthalmopathy are CD8+ and specifically recognize autologous
fibroblasts. J. Clin. Invest. 3, 2738-2743. |
| (d) |
Aniszewski, J.P.
et al. (2000) Relationship between disease duration and
predominant orbital T-cell subset in Graves' ophthalmopathy.
J. Clin. Endocrinol. Metab. 85, 776-780. |
| (e) |
Dickinson, A.J.
and Perros, P. (2001) Controversies in the clinical evaluation
of active thyroid-associated orbitopathy: use of a detailed
protocol with comparative photographs for objective assessment.
Clin. Endocrinol. (Oxf.) 55, 283-303. |
|